miRNAs bridging the gap between the tumor microenvironment and liquid biopsy in cutaneous melanoma
- 1Immunology Laboratory, “Victor Babeş” National Institute of Pathology
- 2Department of Pathology, Colentina Clinical Hospital
- 3Doctoral School, Faculty of Biology, University of Bucharest
Abstract
Cutaneous melanoma remains one of the most challenging neoplasms and the deadliest form of skin cancer. miRNAs are a class of non-coding RNA molecules found in both tissues and body fluids that can negatively regulate gene expression in eukaryotic cells, playing key roles in health and disease. Dysregulated miRNA levels have been linked to various aspects of melanocytic tumor biology, including the transition from benign to malignant stages, immunosuppression, dissemination, and therapy resistance. Here, we provide a timely review of the roles of miRNAs within the cutaneous melanoma tumor microenvironment, emphasizing their impact on immune cell phenotypes and functions, angiogenesis, innate and adaptive immunity, and immune checkpoint expression to help refine future biomarkers and therapeutic targets in the field. We will also address their roles in circular and long non-coding RNA sponging interactions and the potential for translating miRNAs into clinical practice, given their simultaneous presence in both cutaneous melanoma tissues and liquid biopsies. The main challenges and limitations associated with such a translational approach will also be addressed.
Related
- Development and internal validation of machine learning models for predicting lymph node metastasis in cutaneous head and neck melanoma
- 1191 Neoadjuvant phase 1b results: dose escalation of intratumoral PH-762 for cutaneous SCC, melanoma, or Merkel cell ( NCT06014086)
- Machine learning based regulatory T cells related gene signature for predicting the clinical outcome and immunotherapy benefits in skin cutaneous melanoma
- MicroRNAs in Cutaneous Melanoma: Biological Roles, Clinical Utility, and Future Directions
- Beyond Breslow Thickness: Reproducibility and Histopathologic Concordance of Ultra-High-Frequency Ultrasound in Primary Cutaneous Melanoma
BibTeX
@article{neagu2026mirnas,
title = {{miRNAs bridging the gap between the tumor microenvironment and liquid biopsy in cutaneous melanoma}},
author = {Monica Neagu and Elena-Georgiana Dobre and Carolina Constantin},
journal = {Frontiers in Immunology},
year = {2026},
month = oct,
doi = {10.3389/fimmu.2026.1949578},
url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1949578/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - miRNAs bridging the gap between the tumor microenvironment and liquid biopsy in cutaneous melanoma
AU - Monica Neagu
AU - Elena-Georgiana Dobre
AU - Carolina Constantin
PY - 2026
DA - 2026/10/05
JO - Frontiers in Immunology
DO - 10.3389/fimmu.2026.1949578
UR - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1949578/full
AB - Cutaneous melanoma remains one of the most challenging neoplasms and the deadliest form of skin cancer. miRNAs are a class of non-coding RNA molecules found in both tissues and body fluids that can negatively regulate gene expression in eukaryotic cells, playing key roles in health and disease. Dysregulated miRNA levels have been linked to various aspects of melanocytic tumor biology, including the transition from benign to malignant stages, immunosuppression, dissemination, and therapy resistance. Here, we provide a timely review of the roles of miRNAs within the cutaneous melanoma tumor microenvironment, emphasizing their impact on immune cell phenotypes and functions, angiogenesis, innate and adaptive immunity, and immune checkpoint expression to help refine future biomarkers and therapeutic targets in the field. We will also address their roles in circular and long non-coding RNA sponging interactions and the potential for translating miRNAs into clinical practice, given their simultaneous presence in both cutaneous melanoma tissues and liquid biopsies. The main challenges and limitations associated with such a translational approach will also be addressed.
SN - 1664-3224
ER -